HIF-1α-IN-2

HIF-1α-IN-2 is an effective HIF-1α inhibitor with anticancer potencies ( IC 50 s of 28 nM and 15 nM in MDA-MB-231 and MiaPaCa-2 cells, respectively). HIF-1α-IN-2 suppresses HIF-1α expression by blocking transcription and protein translation In Vitro HIF-1α-IN-2 (compound 7f) (5 μM; 72h) suppresses the viability of MDA-MB-231 and MiaPaCa-2 cells with IC 50 s of 28 nM and 15 nM, respectively. HIF-1α-IN-2 (0-1 μM; 72h) suppresses the expression of HIF-1α and VEGF with dose-dependent effect. HIF-1α-IN-2 (0.25, 0.5, and 1 µM; 16-24h) can significantly inhibit the migration of MDA-MD-231 cells by 56% (0.25 µM), 83% (0.5 µM), and 85% (1 µM), respectively, and also noted in MiaPaCa-2 cells, which demonstrates the unique anti-migration effect of HIF-1α-IN-2. HIF-1α-IN-2 (0-1 μM; 72h) suppresses HIF-1α mRNA levels in MDA-MB-231 cells under hypoxia. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability Assay Cell Line: MDA-MB-231 cells, MiaPaCa-2 cellsConcentration: 5 μM Incubation Time: 72 hours Result: Suppressed the viability of these two cell lines with IC 50 of 28 nM and 15 nM in MDA-MB-231 and MiaPaCa-2 cells, respectively. Cell Viability Assay Cell Line: MDA-MB-231 cells, MiaPaCa-2 cellsConcentration: 5 μM Incubation Time: 72 hours Result: Suppressed the viability of these two cell lines with IC 50 of 28 nM and 15 nM in MDA-MB-231 and MiaPaCa-2 cells, respectively. Form:Solid IC50& Target:IC 50 : 28 nM (HIF-1α) in MDA-MB-231, 15 nM (HIF-1α) in MiaPaCa-2

No numbering system information yet

No physical and chemical property information yet

No safety information yet

No production method and use information yet

No upstream information yet

No downstream information yet

No related product information yet